← SynDRA
NAFAMOSTAT
SynDRA canonical compound SYN0000443 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ASIC1 | ASIC2 | ASIC3 | C1R | PRSS1 | TPSAB1 | TRPM7 |
|---|
| Mechanism of action | serine protease inhibitor |
|---|
| Indication | anticoagulent |
|---|
| Disease area | cardiology |
|---|
All known targets
- ASIC1
- ASIC2
- ASIC3
- C1R
- TPSAB1
- PRSS1
- TMPRSS2
- TRPM7
- HGFAC
- F2
- KLK1
- PLG
Mechanisms of action (all sources)
- ASIC1 MODULATOR
- ASIC2 MODULATOR
- ASIC3 MODULATOR
- C1R INHIBITOR
- PRSS1 INHIBITOR
- TMPRSS2 INHIBITOR
- TRPM7 INHIBITOR
- TPSAB1 INHIBITOR
- serine protease inhibitor
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Anticoagulants
- Antirheumatic Agents
- Complement Inactivating Agents
- Enzyme Inhibitors
- Hematologic Agents
- Immunologic Factors
- Immunosuppressive Agents
- Peripheral Nervous System Agents
Cross-references
Synonyms
- nafamostat mesilate
- nafamostat mesylate
- FUT-175
- nafamstat
- nafamostat dihydrochloride
- nafamostat hydrochloride
- nafamostat HCl
- ronastat
- Nafamostat [INN]
- Nafamostatum [Latin]
- UNII-Y25LQ0H97D
- Nafamstat
- Nafamstat Mesilate
- 6-Amidino2-naphthyl 4-guanidinobenzoate
- Y25LQ0H97D
- CHEMBL273264
- C19H17N5O2
- Nafamostat (INN)
- p-Guanidinobenzoic acid ester with 6-hydroxy-2-naphthamidine
- Nafamostatum
- CKD314
- 6'-amidino-2-naphthyl 4-guanidinobenzoate
- RefChem:831686
- 6-carbamimidoylnaphthalen-2-yl 4-carbamimidamidobenzoate
- 6-carbamimidoylnaphthalen-2-yl 4-guanidinobenzoate
- (6-carbamimidoylnaphthalen-2-yl) 4-carbamimidamidobenzoate
- NCGC00160398-01
- Nafabelltan
- NAFAMOSTAT [MI]
- NAFAMOSTAT [WHO-DD]
- BSPBio_001194
- SCHEMBL135503
- SCHEMBL135504
- GTPL4262
- orb1704313
- SCHEMBL29358879
- SCHEMBL29360143
- SCHEMBL29429443
Look up NAFAMOSTAT in the interactive SynDRA portal →